Month: February 2025

Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

Written by Customer Service on February 28, 2025. Posted in Mergers And Acquisitions.

SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously signed binding Term Sheet between Vincerx, Oqory, Inc., and Vivasor, Inc. for a reverse merger transaction has been terminated. As a result, the board of directors will reassess the Company’s strategic alternatives, including out-licensing, merger and acquisition opportunities (including reverse mergers), the sale of assets and technologies, and winding down operations, among other potential transactions. As of February 26, 2025, the Company had approximately $3.9 million in cash. The Company’s cash runway is expected to extend through late Q2 2025. Forward-Looking Statements This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Forward-looking statements,...

4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

Written by Customer Service on February 28, 2025. Posted in Earnings Releases And Operating Results.

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient populations and continued favorable tolerability Announced positive interim 32-week data for 4D-150 in DME from Part 1 of SPECTRA clinical trial and alignment with FDA for a single Phase 3 trial being acceptable for the basis of BLA submission for 4D-150 in DME when combined with data generated from 4FRONT Phase 3 trials in wet AMD 4FRONT Phase 3 program in wet AMD on track with initiation of 4FRONT-1 expected in March 2025 and 4FRONT-2 in Q3 2025, with topline data from both studies expected in 2H 2027 Strategically focused pipeline to optimize resource allocation and extend cash runway to advance product candidates with strongest clinical proof...

Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update

Written by Customer Service on February 28, 2025. Posted in Earnings Releases And Operating Results.

Wa’el HashadWa’el Hashad, Chief Executive Officer, Longeveron Inc.Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease and orphan-designated indication, has achieved more than 90% enrollment and is expected to complete enrollment in the second quarter of 2025 Lomecel-B™ Biological License Application (BLA) submission for full traditional approval anticipated in 2026, if ELPIS II is successful FDA meeting anticipated late in first quarter of 2025 to discuss possible development paths for Lomecel-B™ in mild Alzheimer’s disease WHO International Nonproprietary Names (INN) Expert Committee approved “laromestrocel” for the non-proprietary name of Lomecel-B™ Total Revenue for 2024 increased 237% year-over-year...

Quisitive Shareholders Approve Acquisition by H.I.G. Capital

Written by Customer Service on February 28, 2025. Posted in Mergers And Acquisitions.

TORONTO, Feb. 28, 2025 (GLOBE NEWSWIRE) — Quisitive Technology Solutions Inc. (“Quisitive” or the “Company”) (TSXV: QUIS; OTCQX: QUISF), a premier Microsoft Cloud and AI solutions provider, is pleased to announce that its shareholders (the “Shareholders”) approved the special resolution authorizing the proposed acquisition of Quisitive by an affiliate of funds managed by H.I.G. Capital, LLC pursuant to a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”). The special resolution approving the Arrangement was approved by (i) 98.55% of the votes cast by Shareholders present in person (virtually) or represented by proxy and entitled to vote at the special meeting (the “Meeting”) to consider the Arrangement, and (ii) 98.29% of the votes cast by Shareholders present in person (virtually) or...

Verizon declares quarterly dividend on February 28

Written by Customer Service on February 28, 2025. Posted in Dividend Reports And Estimates.

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — The Board of Directors at Verizon Communications Inc. (NYSE, Nasdaq: VZ) today declared a quarterly dividend of 67.75 cents per outstanding share, unchanged from the previous quarter. The quarterly dividend is payable on May 1, 2025, to Verizon shareholders of record at the close of business on April 10, 2025. Verizon demonstrated strong performance in 2024, as it more than doubled wireless postpaid phone net additions compared to 2023, and continued to take broadband market share with Fios and fixed wireless access. The company delivered on financial guidance with impactful revenue growth and operational results and is well positioned to meet its 2025 financial guidance and operational goals. “As the industry leader with 18 consecutive years of dividend increases, we see Verizon’s growth...

Silvano Fashion Group Consolidated Interim Financial Report for Q4 and 12m of 2024 (unaudited)

Written by Customer Service on February 28, 2025. Posted in Public Companies.

Silvano Fashion Group Consolidated Interim Financial Report for Q4 and 12m of 2024 (unaudited) Selected Financial Indicators Summarized selected financial indicators of the Group for 12 months of 2024 compared to 12 months of 2023 and 31.12.2024 compared to 31.12.2023 were as follows: in thousands of EUR 12m 2024 12m 2023 ChangeRevenue 58 070 58 597 -0.9%Gross Profit 34 278 33 743 1.6%Operating profit 17 248 17 973 -4.0%EBITDA 20 316 21 120 -3.8%Net profit for the period 13 673 11 107 23.1%Net profit attributable equity holders of the Parent company 12 366 9 927 24.6%Earnings per share (EUR) 0,34 0,28 21.4%Operating cash flow for the period 11 164 11 703 -4.6% in thousands of EUR 31.12.2024 31.12.2023 ChangeTotal assets 84 489 72 252 16.9%Total current assets 70...

NANO Nuclear Energy Announces Active Corporate Role for Veteran Investment & Merchant Banker Darlene T. DeRemer as its Executive Director of Corporate Finance

Written by Customer Service on February 28, 2025. Posted in Public Companies.

Figure 1NANO Nuclear Energy Executive Advisory Board Member Darlene T. DeRemer Transitions to Active Role within the Company as its Executive Director of Corporate Finance.New York, N.Y., Feb. 28, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that Darlene T. DeRemer, previously Chairwoman of NANO Nuclear’s Executive Advisory Board for Institutional Finance, has now transitioned to a new, active corporate role with NANO Nuclear as its Executive Director of Corporate Finance. In her new role, Ms. DeRemer will assist NANO Nuclear’s executive management as a consultant in the continuing development and execution of the Company’s financing strategies and its...

Superior Energy Services Acquires Rival Downhole Tools

Written by Customer Service on February 28, 2025. Posted in Mergers And Acquisitions.

HOUSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) — Superior Energy Services, Inc (“Superior”) announced the acquisition of Rival Downhole Tools (“Rival”), an industry-leading provider of premium downhole drilling tools. “This acquisition is part of Superior’s ongoing efforts to expand our position in the oilfield services sector by providing technologies that enhance our customers’ efficiencies and reduce their costs,” said Dave Lesar, Superior’s Chairman and Chief Executive Officer. “Rival is a recognized leader in downhole drilling solutions and, as it’s combined with our existing Stabil Drill business, will create a premier drilling rental product offering for our customers. We are proud to bring them under the Superior banner.” Founded in 2017, Rival has long been known for its portfolio of innovative downhole tools engineered to mitigate...

Canadian Gold Resources (TSXV: CAN) Terminates Investor Relations Agreement; Supplemental Information and Clarification on Option Grants

Written by Customer Service on February 28, 2025. Posted in Public Companies.

DIEPPE, New Brunswick, Feb. 28, 2025 (GLOBE NEWSWIRE) — Canadian Gold Resources Ltd. (“Canadian Gold” or the “Company”) (TSXV: CAN) announces that, effective as of February 21, 2025, it has terminated its investor relations agreement with Alliance Advisors, LLC (the “Agreement”) (see the Company’s news release dated January 20, 2025). As a result, the Company has withdrawn its application to TSXV to accept the Agreement. The decision to terminate was made after careful consideration of the Company’s strategic direction and continuing challenges in respect of the operating terms of the Agreement for both parties. The Company remains committed to enhancing shareholder value and will explore alternative options to ensure effective communication with its stakeholders and the broader investment community. The...

Healthcare Realty Trust Announces Participation in Citi’s 2025 Global Property CEO Conference and Provides Update on Rent Collection From Prospect Medical

Written by Customer Service on February 28, 2025. Posted in Public Companies.

NASHVILLE, Tenn., Feb. 28, 2025 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) (“Healthcare Realty” or the “Company”) today announced that members of the Company’s management team will participate in Citi’s 2025 Global Property CEO Conference on March 3 – 4, 2025. The Company also published an updated investor presentation in advance of the conference and other upcoming investor meetings. The presentation is available at the Investor Relations section of the company’s website at https://investors.healthcarerealty.com/corporate-profile/. Healthcare Realty also announced the partial collection of rent payments from Prospect Medical for the months of January and February 2025, totaling $0.4 million. As the Company has previously disclosed, Prospect Medical filed for Chapter 11 bankruptcy protection on January 11,...

Month: February 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals